BRNS logo

BRNS Enterprise Value

Enterprise Value

-$53.53 M
-$321.83 K-0.60%

5 min ago


Summary


Performance

BRNS Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherBRNSvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

BRNS Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday-0.6%-0.8%-0.8%
1 m1 month-1.4%-1.8%-1.8%
3 m3 months+1.9%+2.7%+2.7%
6 m6 months+10.0%-12.8%-14.5%
ytdytd-18.5%-17.3%-17.3%
1 y1 year-112.7%-61.6%-63.1%
5 y5 years---

BRNS Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-10.6%-$56 M+4.5%
3 m3-month-$44 M-22.9%-$60 M+11.4%
6 m6-month-$32 M-65.8%-$60 M+11.4%
1 y1-year$19 M-379.2%-$66 M+18.5%
3 y3-year$66 M-181.6%-$109 M+50.8%
5 y5-year$425 M-112.6%-$109 M+50.8%
alltimeall time$425 M-112.6%-$109 M+50.8%

Barinthus Biotherapeutics Enterprise Value History

DateValue
2025
-$53.53 M(+18.5%)
2024
-$45.16 M(-435.0%)
DateValue
2023
$13.48 M(-113.9%)
2022
-$97.06 M(-147.0%)
2021
$206.33 M

FAQ

  • What is Barinthus Biotherapeutics enterprise value?
  • What is the all time high enterprise value for Barinthus Biotherapeutics?
  • What is BRNS enterprise value year-to-date change?
  • What is Barinthus Biotherapeutics enterprise value year-on-year change?

What is Barinthus Biotherapeutics enterprise value?

The current enterprise value of BRNS is -$53.53 M

What is the all time high enterprise value for Barinthus Biotherapeutics?

Barinthus Biotherapeutics all-time high enterprise value is $424.79 M

What is BRNS enterprise value year-to-date change?

Barinthus Biotherapeutics enterprise value has changed by -$8.37 M (-18.53%) since the beginning of the year

What is Barinthus Biotherapeutics enterprise value year-on-year change?

Over the past year, BRNS enterprise value has changed by -$28.36 M (-112.72%)